Apr 12, 2019 Seladelpar for the Treatment of Primary Biliary Cholangitis: Experience with 25 Cirrhotic Patients
Jan 21, 2019 Efficacy of Seladelpar for Amelioration of Fibrosis and NASH in a Diet-Induced and Biopsy- Confirmed Mouse Model: Comparison to Liraglutide, Selonsertib and Obeticholic Acid
Jan 15, 2019 Combination Therapy of Seladelpar and Liraglutide Attenuates Obesity, Hepatic Steatosis and Fibrosis in a Diet Mouse Model of NASH
Nov 13, 2018 Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, Randomized, Dose-Ranging Phase 2 Study
Nov 12, 2018 Efficacy and Safety of Seladelpar in Primary Biliary Cholangitis 52-Week Analysis of a Dose-Ranging Phase 2 Study
Nov 10, 2018 Seladelpar Improves Hepatic Steatohepatitis and Fibrosisin a Diet-Induced and Biopsy-Confirmed Mouse Model of NASH
Apr 11, 2018 Pharmacokinetics and Pharmacodynamics of Seladelpar, a Potent and Selective PPAR- Agonist, in Patients with Primary Biliary Cholangitis
Apr 11, 2018 Seladelpar’s Mechanism of Action as a Potential Treatment for Primary Biliary Cholangitis and Non-Alcoholic Steatohepatitis
